<DOC>
	<DOCNO>NCT00002359</DOCNO>
	<brief_summary>To determine effect HIV-1 immunogen ( Remune ) AIDS-free survival , define time prior development AIDS-defining condition death .</brief_summary>
	<brief_title>A Multicenter , Double-Blind , Phase III , Adjuvant-Controlled Study Effect 10 Units HIV-1 Immunogen ( Remune ) Compared Incomplete Freund 's Adjuvant ( IFA ) Alone Every 12 Weeks AIDS-Free Survival Subjects With HIV Infection CD4 T-Lymphocytes Between 300 549 Cells/microL Rega</brief_title>
	<detailed_description>Patients receive 10 unit HIV-1 immunogen IFA IFA alone every 12 week , follow 104-148 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Freund 's Adjuvant</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretrovirals stable dose least past 3 month . Patients must : HIV1 infection CD4 count 300549 cells/mm3 . No AIDSdefining condition . Been stable dose antiretroviral past 3 month , take antiretrovirals . NOTE : KS permit require systemic therapy . Prior Medication : Allowed : Prior antiretrovirals . Exclusion Criteria Concurrent Medication : Excluded : Systemic chemotherapy KS . Treatment malignancy basal cell squamous cell carcinoma skin carcinoma situ cervix . Patients follow prior condition exclude : History illness would interfere study . Acute infection require prescription therapy within past month , genital herpes oral vaginal candidiasis . Prior Medication : Excluded : Prior HIV1 Immunogen . Unwilling use effective safe sex practice . Active substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1997</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>Viral Vaccines</keyword>
	<keyword>HIV-1</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Salk HIV Immunogen</keyword>
</DOC>